News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
507,914 Results
Type
Article (58962)
Company Profile (97)
Press Release (448844)
Multimedia
Podcasts (233)
Webinars (34)
Section
Business (136243)
Career Advice (1841)
Deals (20967)
Drug Delivery (141)
Drug Development (57147)
Employer Resources (188)
FDA (10295)
Job Trends (11766)
News (227305)
Policy (21221)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2904)
Academic (1)
Accelerated approval (48)
ADA (31)
Adcomms (27)
Allergies (138)
Alliances (38977)
ALS (179)
Alzheimer's disease (1652)
Antibody-drug conjugate (ADC) (403)
Approvals (10587)
Artificial intelligence (656)
ASCO (242)
Autoimmune disease (249)
Automation (41)
Bankruptcy (156)
Best Places to Work (8996)
BIO (49)
BIOSECURE Act (21)
Biosimilars (155)
Biotechnology (66)
Bladder cancer (139)
Brain cancer (69)
Breast cancer (595)
Cancer (4977)
Cardiovascular disease (374)
Career advice (1582)
Career pathing (51)
CAR-T (283)
CDC (60)
Celiac Disease (2)
Cell therapy (773)
Cervical cancer (44)
Clinical research (48162)
Collaboration (1924)
Commercialization (1)
Company closure (4)
Compensation (274)
Complete response letters (61)
COVID-19 (2515)
CRISPR (105)
C-suite (866)
Cystic fibrosis (135)
Data (6408)
Decentralized trials (3)
Denatured (93)
Depression (149)
Dermatology (67)
Diabetes (451)
Diagnostics (5185)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (48)
Drug discovery (351)
Drug pricing (206)
Drug shortages (28)
Duchenne muscular dystrophy (256)
Earnings (50524)
Editorial (74)
Employer branding (24)
Employer resources (160)
Events (65405)
Executive appointments (813)
FDA (13049)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (25)
Funding (1516)
Gene editing (209)
Generative AI (60)
Gene therapy (611)
GLP-1 (882)
Government (4160)
Grass and pollen (4)
Guidances (366)
Healthcare (14467)
Hematology (132)
HIV (76)
Huntington's disease (46)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (76)
Immunology and inflammation (222)
Immuno-oncology (90)
Indications (161)
Infectious disease (2814)
Inflammatory bowel disease (167)
Inflation Reduction Act (14)
Influenza (100)
Intellectual property (210)
Interviews (341)
IPO (9446)
IRA (53)
Job creations (2930)
Job search strategy (1316)
JPM (67)
Kidney cancer (16)
Labor market (122)
Layoffs (481)
Leadership (38)
Legal (4166)
Liver cancer (70)
Longevity (29)
Lung cancer (645)
Lymphoma (378)
Machine learning (56)
Management (57)
Manufacturing (873)
Marketing (4)
MASH (161)
Medical affairs (1)
Medical device (8404)
Medtech (8499)
Mergers & acquisitions (12422)
Metabolic disorders (1201)
mRNA (229)
Multiple sclerosis (157)
NASH (18)
Neurodegenerative disease (385)
Neuropsychiatric disorders (83)
Neuroscience (2974)
Neurotech (1)
NextGen: Class of 2026 (5097)
Non-profit (4647)
Now hiring (80)
Obesity (544)
Opinion (300)
Ovarian cancer (204)
Pain (196)
Pancreatic cancer (275)
Parkinson's disease (340)
Partnered (34)
Patents (399)
Patient recruitment (519)
Peanut (46)
People (43239)
Pharmaceutical (18)
Pharmacy benefit managers (26)
Phase 1 (14883)
Phase 2 (20858)
Phase 3 (16259)
Pipeline (7630)
Policy (354)
Postmarket research (2048)
Preclinical (7785)
Press Release (67)
Prostate cancer (270)
Psychedelics (67)
Radiopharmaceuticals (263)
Rare diseases (903)
Real estate (5079)
Recruiting (73)
Regulatory (17107)
Reports (73)
Research institute (2710)
Resumes & cover letters (277)
Rett syndrome (24)
RNA editing (21)
RSV (69)
Schizophrenia (145)
Series A (230)
Series B (152)
Service/supplier (12)
Sickle cell disease (99)
Special edition (33)
Spinal muscular atrophy (143)
Sponsored (46)
Startups (2826)
State (1)
Stomach cancer (9)
Supply chain (102)
Tariffs (87)
The Weekly (137)
Vaccines (1049)
Venture capital (122)
Weight loss (380)
Women's health (119)
Worklife (24)
Date
Today (81)
Last 7 days (360)
Last 30 days (1643)
Last 365 days (20430)
2026 (10909)
2025 (20707)
2024 (24394)
2023 (28074)
2022 (38072)
2021 (40956)
2020 (39228)
2019 (34956)
2018 (26385)
2017 (23127)
2016 (23128)
2015 (27079)
2014 (20484)
2013 (17635)
2012 (17935)
2011 (18672)
2010 (17215)
Location
Africa (794)
Alabama (91)
Alaska (4)
Arizona (228)
Arkansas (14)
Asia (31464)
Australia (5829)
California (8526)
Canada (2737)
China (1256)
Colorado (379)
Connecticut (401)
Delaware (303)
Europe (71241)
Florida (1430)
Georgia (336)
Hawaii (1)
Idaho (40)
Illinois (802)
India (78)
Indiana (459)
Iowa (25)
Japan (462)
Kansas (83)
Kentucky (39)
Louisiana (43)
Maine (25)
Maryland (1172)
Massachusetts (6208)
Michigan (257)
Minnesota (474)
Mississippi (6)
Missouri (121)
Montana (23)
Nebraska (21)
Nevada (103)
New Hampshire (47)
New Jersey (2746)
New Mexico (32)
New York (2711)
North Carolina (1326)
North Dakota (9)
Northern California (4260)
Ohio (283)
Oklahoma (19)
Oregon (25)
Pennsylvania (1686)
Puerto Rico (13)
Rhode Island (35)
South America (885)
South Carolina (48)
South Dakota (2)
Southern California (3447)
Tennessee (146)
Texas (1479)
United States (32314)
Utah (244)
Vermont (1)
Virginia (243)
Washington D.C. (66)
Washington State (850)
West Virginia (3)
Wisconsin (100)
Wyoming (1)
507,914 Results for "national space biomedical research institute nsbri".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Foundation for the National Institutes of Health Announces Recipients of the Deeda Blair Research Initiative for Disorders of the Brain
May 20, 2026
·
4 min read
China
New biotech group rises to fuel American rockets in China ‘space race’
Members of the American Biotech Innovation Alliance (ABIA) want to build a national biotech strategy—just like China did years ago.
June 10, 2026
·
3 min read
·
Annalee Armstrong
Rare diseases
Prasad’s Departure Could Be ‘Big Win’ for Biotech—Especially Rare Disease Space: Analysts
Some biotechs that had seen regulatory setbacks under Center for Biologics Evaluation and Research director Vinay Prasad experienced stock bumps Monday morning. Under Prasad’s leadership, the rare disease space has suffered a series of controversial rejections.
March 9, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure
February 10, 2026
·
4 min read
Press Releases
Leading Parkinson’s Organizations Urge Congress to Preserve Progress and Strengthen Parkinson’s Research Funding at the National Institutes of Health
April 5, 2026
·
4 min read
Press Releases
Starlab Space and Auxilium Biotechnologies to Advance Life Sciences Research in Microgravity
February 10, 2026
·
3 min read
Press Releases
Cartilage Tissue Engineering Heads to Orbit in NSF and NASA-supported Study at the International Space Station
June 29, 2026
·
2 min read
Press Releases
National Cancer Institute Awards Rosalind Franklin University Researcher Grant to Crack the Epigenetic Code of Pancreatic Cancer Muscle Wasting
March 26, 2026
·
1 min read
Press Releases
START Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey
Strengthening clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets
April 30, 2026
·
1 min read
Gene therapy
4 spaces primed for the next wave of gene therapies
The recent approval of Regeneron’s Otarmeni underscores the maturation of gene therapies across a range of diseases. Here,
BioSpace
reviews genetic medicines in development for the central nervous system, retinal, cardiac and neuromuscular diseases.
May 18, 2026
·
8 min read
·
Andrea Park
1 of 50,792
Next
